TrialAntimicrobial agents and chemotherapy2012

Randomized trial of entecavir plus adefovir in patients with lamivudine-resistant chronic hepatitis B who show suboptimal response to lamivudine plus adefovir.

Young-Suk Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.